Viewing nowCombinationRosucande Tablet 10/16 mg
Rosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Geonil Biopharm Co., Ltd.

MFDS item code 202107115 · Approved 2021.10.25 · Insurance code 073000710
Treatment of dyslipidemia, hypertension, and heart failure; inhibition of atherosclerosis progression; prevention of cardiovascular disease
This medication is used for patients who need to take Candesartan Cilexetil and Rosuvastatin together. Candesartan Cilexetil is mainly used for the treatment of essential hypertension and for patients with heart failure with decreased left ventricular function when additional therapy with ACE inhibitors is required or when there is intolerance to ACE inhibitors. Rosuvastatin is used as an adjunct for patients with hypercholesterolemia and mixed dyslipidemia when dietary control is insufficient, and it is also used in the treatment of familial hypercholesterolemia and dysbetalipoproteinemia. Furthermore, Rosuvastatin helps to slow the progression of atherosclerosis and reduces the risk of stroke, myocardial infarction, and vascular reintervention in patients at high risk for cardiovascular disease. This medication improves cardiovascular health by simultaneously controlling blood pressure and cholesterol.
This medicine is for use in adults only. The dose should be individualized for each patient based on the effects and tolerability of each ingredient, candesartan cilexetil and rosuvastatin. ○ Candesartan cilexetil 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Administer an initial dose of 4 mg with careful caution in patients at high risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks and increased to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted as a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking candesartan cilexetil and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience of administration.
Essential hypertension: The safety and efficacy in adolescents and children aged 18 years or younger have not been established. Heart failure: The safety and efficacy in adolescents and children aged 18 years or younger have not been established.
This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be administered to those with hypersensitivity to this medication or to patients with liver disease, severe hepatic impairment, severe renal failure, myopathy, hereditary angioedema, etc. Caution is warranted for elderly patients or those with hyperkalemia, liver impairment, and it is important to regularly check liver function and muscle status. If symptoms such as muscle pain or weakness occur, consult a doctor immediately, and blood tests may be needed to confirm muscle damage. The risk of side effects may increase when taken with other antihypertensives or specific medications, so it is essential to inform healthcare providers of any medications being taken. Women who are pregnant or breastfeeding should not use this medication, and women of childbearing age should use appropriate contraception. It is not recommended for children as safety and efficacy in this age group have not been established. In the case of overdose, appropriate treatment is required based on the symptoms, as there is no specific antidote, and guidance should be followed from healthcare providers. Dizziness or fatigue may occur while taking this medication, so caution is needed when driving or operating machinery. When storing this medication, keep it out of reach of children, and it is advised not to transfer the medication from its original container to another one.
Headache, nasopharyngitis, localized infection, fatigue, generalized pruritus, dermatitis, itching, joint stiffness, limb pain, photophobia, dyspepsia, nausea, hyperglycemia, hyponatremia, hand fracture, hypoglycemia, nephrolithiasis, cough, headache, itching, nausea, dizziness, positional vertigo, miliaria, periodontitis, inflammation, foreign body sensation, musculoskeletal pain, neck pain, cataract, chest discomfort, hyperglycemia, hyponatremia, hand fracture, hypoglycemia, nephrolithiasis, cough, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, dyspnea, diarrhea, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe muscle weakness, ocular myasthenia, hypotension, hyperkalemia, kidney function impairment, creatinine increase, urea increase, potassium increase, sodium decrease, ALT elevation, dizziness, weakness, fever, paresthesia, dyspepsia, gastroenteritis, tachycardia, palpitations, hyperglycemia, hypertriglyceridemia, hyperuricemia, myalgia, nasal bleeding, anxiety, depression, drowsiness, dyspnea, rash, increased sweating, hematuria, intestinal vascular edema, diarrhea, liver dysfunction, jaundice, thrombocytopenia, acute kidney failure, shock, syncope, loss of consciousness, paralysis, hypertonia, syncope, facial flushing, weight gain, facial edema, dry mouth, sleep disorders, decreased libido, forgetfulness, loss of appetite, increased appetite, tinnitus, taste distortion, erectile dysfunction, constipation, abdominal pain, pancreatitis, arthralgia, low back pain, myalgia, joint pain, numbness, sensory disturbance, chest discomfort, abdominal distension, syncope, generalized pain, muscle cramps, gout
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is safe to store it at room temperature between 1°C and 30°C. Proper storage will prolong the effectiveness of the medication.
Yellow round film-coated tablets
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Geonil Biopharm Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.